Odylia Announces Promotion of Ashley Winslow to President and Chief Scientific Officer
Odylia is looking forward to helping the SATB2 Gene Foundation further SATB2 research through this new partnership....
15 February, 2022
Odylia Therapeutics Granted Orphan Drug and Rare Pediatric Disease Designations by the FDA for OT-004, an Investigational Gene Therapy for RPGRIP1- associated Retinal Dystrophies
Odylia is looking forward to helping the SATB2 Gene Foundation further SATB2 research through this new partnership....
15 November, 2021
Odylia announces new partnership with CLOVES Syndrome Community
Odylia is looking forward to helping the SATB2 Gene Foundation further SATB2 research through this new partnership....
21 October, 2021
Odylia to Host a Free Webinar on RPGRIP1 Gene Therapy Program
Odylia Therapeutics will be discussing our RPGRIP1 Gene Therapy program to treat vision loss in patients diagnosed with Leber Congenital Amaurosis 6 (LCA6). Join us to learn more about Odylia Therapeutics and the progress of our gene therapy program, as well as next steps. Meeting details: Tuesday,...
15 September, 2021
Odylia announces new partnership with the SATB2 Gene Foundation
Odylia is looking forward to helping the SATB2 Gene Foundation further SATB2 research through this new partnership....
24 February, 2021
Tiansen Li joins Odylia Advisory Board
“We are very excited to have Tainsen join the Odylia Advisory Board,” said Scott Dorfman, Odylia Therapeutics’ CEO....
09 November, 2020
Odylia and Foundation Fighting Blindness will host a 4-part webinar series starting October 8th
Odylia and Foundation Fighting Blindness are hosting a 4-part preclinical and translational research webinar series. The series will focus on genetic technologies and will provide advice and educational materials to researchers in the rare disease space. If you are currently working in or thinking about preclinical...
21 September, 2020
Sharing Insight for Gene Therapy Manufacturing
Converting vertical information approaches into horizontal solutions for all members of the rare disease community....
04 March, 2020
Ashley Winslow joins the Odylia team
Dr. Winslow will oversee scientific operations and strategy development with a focus on expanding partnerships....
05 November, 2019